ATS Corporation reported a solid fiscal 2026, with full-year revenue growth of approximately 11% and adjusted earnings from operations rising 3.4% to $76.8 million in Q4. However, the company faced challenges, with Q4 order bookings declining 18.4% due to the absence of large prior-period orders. The backlog remains robust at $2 billion, primarily driven by Life Sciences and a significant 40% increase in the Energy segment, particularly in nuclear-related work.
The company’s strategic shift includes consolidating its transportation segment, eliminating $50 million in dilutive revenue, and focusing on higher-margin services. Management anticipates modest revenue growth for fiscal 2027, alongside projected margin improvements of 50 to 75 basis points, despite ongoing restructuring costs. This approach aims to enhance operational efficiency and capitalize on strong demand in regulated markets.
For market professionals, ATS’s ability to pivot towards high-growth sectors like Life Sciences and Energy, while managing restructuring effectively, signals a disciplined approach to capital allocation and margin expansion that could enhance shareholder value in the long term.
Source: fool.com